http://www.legislation.gov.uk/eur/2017/1413Commission Regulation (EU) 2017/1413 of 3 August 2017 amending Annex IV to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Text with EEA relevance)Commission Regulation (EU) 2017/1413Commission Regulation (EU) 2017/1413 of 3 August 2017 amending Annex IV to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Text with EEA relevance)2020-12-12King's Printer of Acts of Parliamenthttps://webarchive.nationalarchives.gov.uk/eu-exit/https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32017R1413texttext/xmlen2017-08-03

Commission Regulation (EU) 2017/1413

of 3 August 2017

amending Annex IV to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products

OJ L 342, 22.12.2009, p. 59.

, and in particular Article 31(1) thereof,

Whereas:

(1)

Zinc oxide is authorised as a colorant in cosmetic products under entry 144 of Annex IV to Regulation (EC) No 1223/2009.

(2)

In its opinion of 18 September 2012

SCCS/1489/12 Revision of 11 December 2012, http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_103.pdf

, which was revised in 23 September 2014

SCCS/1539/14 Revision of 25 June 2015, http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_163.pdf

, the Scientific Committee on Consumer Safety (SCCS) concluded that the use of zinc oxide is safe when used as colorant, in its uncoated non-nano form, in cosmetics for dermal application. However, the SCCS also considered that in view of the lung inflammation induced by zinc oxide particles after inhalation, the use of zinc oxide in cosmetic products that may result in exposure of the consumer's lungs to zinc oxide by inhalation was of concern.

(3)

In light of the SCCS opinions, the use of zinc oxide as a colorant, in its uncoated non-nano form, in cosmetic products should be restricted to those applications which may not lead to exposure of the end-user's lungs by inhalation.

(4)

Annex IV to Regulation (EC) No 1223/2009 should therefore be amended accordingly.

(5)

The industry should be allowed a reasonable period of time to make the necessary adjustments to product formulations in view of their placing on the market and for the withdrawal of non-compliant products from the market.

(6)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Cosmetic Products,

HAS ADOPTED THIS REGULATION:

Article 1

Annex IV to Regulation (EC) No 1223/2009 is amended in accordance with the Annex to this Regulation.

Article 2

From 24 February 2018 only cosmetic products which comply with this Regulation shall be placed on the Union market.

From 24 May 2018 only cosmetic products which comply with this Regulation shall be made available on the Union market.

Article 3

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 3 August 2017.

For the Commission

The President

Jean-Claude Juncker

ANNEX

Entry 144 of Annex IV to Regulation (EC) No 1223/2009 is replaced by the following:

Reference number

Substance identification

Conditions

Wording of conditions of use and warnings

Chemical Name

Colour index Number/Name of Common Ingredients Glossary

CAS number

EC number

Colour

Product type, Body parts

Maximum concentration in ready for use preparation

Other

a

b

c

d

e

f

g

h

i

j

‘144

Zinc oxide

For use as a UV-filter, see Annex VI, No 30 and No 30a.’.

77947

1314-13-2

215-222-5

White

Not to be used in applications that may lead to exposure of the end-user's lungs by inhalation.